Click for best price
AntiHER2 Therapy Market Size, Share 2023
Anti-HER2 Therapy is a class of medicines used to treat all stages of HER2-positive breast cancer and certain HER2-low breast cancers.In HER2-positive breast cancer, the HER2 (human epidermal growth factor receptor 2) gene doesn?t work correctly and makes too many copies of itself. These extra HER2 genes make too many proteins known as HER2 receptors.Anti-HER2 medicines attach to the HER2 receptor proteins on the surface of breast cancer cells.Anti-HER2 medicines work by blocking the HER2 receptors from receiving the growth signals in HER2-positive breast cancer. By blocking the growth signals, anti-HER2 medicines can slow or stop the growth of HER2-positive and HER2-low breast cancer. Anti-HER2 medicines only work on HER2-positive and HER2-low breast cancer. They do not work on HER2-negative breast cancer.
This report aims to provide a comprehensive presentation of the global market for Anti-HER2 Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-HER2 Therapy. This report contains market size and forecasts of Anti-HER2 Therapy in global, including the following market information:
Global Anti-HER2 Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anti-HER2 Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Anti-HER2 Monoclonal Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-HER2 Therapy include GlaxoSmithKline, Bayer, Abbott, AbbVie, Pfizer, Sanofi, Merck, Glenmark Pharmaceuticals and Roche, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-HER2 Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-HER2 Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anti-HER2 Therapy Market Segment Percentages, by Type, 2022 (%)
Anti-HER2 Monoclonal Antibodies
Antibody-Drug Conjugate
Kinase Inhibitors
Global Anti-HER2 Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anti-HER2 Therapy Market Segment Percentages, by Application, 2022 (%)
Online Pharmacy
Retail Pharmacy
Medical Clinics
Global Anti-HER2 Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anti-HER2 Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-HER2 Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-HER2 Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Bayer
Abbott
AbbVie
Pfizer
Sanofi
Merck
Glenmark Pharmaceuticals
Roche
Novartis
Astra Zeneca
Daiichi Sankyo
Celltrion
Teva
Biocon
Viatris
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-HER2 Therapy, market overview.
Chapter 2: Global Anti-HER2 Therapy market size in revenue.
Chapter 3: Detailed analysis of Anti-HER2 Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-HER2 Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-HER2 Therapy Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
109 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-HER2 Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-HER2 Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-HER2 Therapy Overall Market Size
2.1 Global Anti-HER2 Therapy Market Size: 2022 VS 2029
2.2 Global Anti-HER2 Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-HER2 Therapy Players in Global Market
3.2 Top Global Anti-HER2 Therapy Companies Ranked by Revenue
3.3 Global Anti-HER2 Therapy Revenue by Companies
3.4 Top 3 and Top 5 Anti-HER2 Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-HER2 Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-HER2 Therapy Players in Global Market
3.6.1 List of Global Tier 1 Anti-HER2 Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-HER2 Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-HER2 Therapy Market Size Markets, 2022 & 2029
4.1.2 Anti-HER2 Monoclonal Antibodies
4.1.3 Antibody-Drug Conjugate
4.1.4 Kinase Inhibitors
4.2 By Type - Global Anti-HER2 Therapy Revenue & Forecasts
4.2.1 By Type - Global Anti-HER2 Therapy Revenue, 2018-2023
4.2.2 By Type - Global Anti-HER2 Therapy Revenue, 2024-2029
4.2.3 By Type - Global Anti-HER2 Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-HER2 Therapy Market Size, 2022 & 2029
5.1.2 Online Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Medical Clinics
5.2 By Application - Global Anti-HER2 Therapy Revenue & Forecasts
5.2.1 By Application - Global Anti-HER2 Therapy Revenue, 2018-2023
5.2.2 By Application - Global Anti-HER2 Therapy Revenue, 2024-2029
5.2.3 By Application - Global Anti-HER2 Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-HER2 Therapy Market Size, 2022 & 2029
6.2 By Region - Global Anti-HER2 Therapy Revenue & Forecasts
6.2.1 By Region - Global Anti-HER2 Therapy Revenue, 2018-2023
6.2.2 By Region - Global Anti-HER2 Therapy Revenue, 2024-2029
6.2.3 By Region - Global Anti-HER2 Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Anti-HER2 Therapy Revenue, 2018-2029
6.3.2 US Anti-HER2 Therapy Market Size, 2018-2029
6.3.3 Canada Anti-HER2 Therapy Market Size, 2018-2029
6.3.4 Mexico Anti-HER2 Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Anti-HER2 Therapy Revenue, 2018-2029
6.4.2 Germany Anti-HER2 Therapy Market Size, 2018-2029
6.4.3 France Anti-HER2 Therapy Market Size, 2018-2029
6.4.4 U.K. Anti-HER2 Therapy Market Size, 2018-2029
6.4.5 Italy Anti-HER2 Therapy Market Size, 2018-2029
6.4.6 Russia Anti-HER2 Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Anti-HER2 Therapy Market Size, 2018-2029
6.4.8 Benelux Anti-HER2 Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Anti-HER2 Therapy Revenue, 2018-2029
6.5.2 China Anti-HER2 Therapy Market Size, 2018-2029
6.5.3 Japan Anti-HER2 Therapy Market Size, 2018-2029
6.5.4 South Korea Anti-HER2 Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Anti-HER2 Therapy Market Size, 2018-2029
6.5.6 India Anti-HER2 Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Anti-HER2 Therapy Revenue, 2018-2029
6.6.2 Brazil Anti-HER2 Therapy Market Size, 2018-2029
6.6.3 Argentina Anti-HER2 Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-HER2 Therapy Revenue, 2018-2029
6.7.2 Turkey Anti-HER2 Therapy Market Size, 2018-2029
6.7.3 Israel Anti-HER2 Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Anti-HER2 Therapy Market Size, 2018-2029
6.7.5 UAE Anti-HER2 Therapy Market Size, 2018-2029
7 Anti-HER2 Therapy Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Anti-HER2 Therapy Major Product Offerings
7.1.4 GlaxoSmithKline Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Anti-HER2 Therapy Major Product Offerings
7.2.4 Bayer Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Abbott
7.3.1 Abbott Company Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Anti-HER2 Therapy Major Product Offerings
7.3.4 Abbott Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.3.5 Abbott Key News & Latest Developments
7.4 AbbVie
7.4.1 AbbVie Company Summary
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Anti-HER2 Therapy Major Product Offerings
7.4.4 AbbVie Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.4.5 AbbVie Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Anti-HER2 Therapy Major Product Offerings
7.5.4 Pfizer Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Anti-HER2 Therapy Major Product Offerings
7.6.4 Sanofi Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.6.5 Sanofi Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Anti-HER2 Therapy Major Product Offerings
7.7.4 Merck Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 Glenmark Pharmaceuticals
7.8.1 Glenmark Pharmaceuticals Company Summary
7.8.2 Glenmark Pharmaceuticals Business Overview
7.8.3 Glenmark Pharmaceuticals Anti-HER2 Therapy Major Product Offerings
7.8.4 Glenmark Pharmaceuticals Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.8.5 Glenmark Pharmaceuticals Key News & Latest Developments
7.9 Roche
7.9.1 Roche Company Summary
7.9.2 Roche Business Overview
7.9.3 Roche Anti-HER2 Therapy Major Product Offerings
7.9.4 Roche Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.9.5 Roche Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Anti-HER2 Therapy Major Product Offerings
7.10.4 Novartis Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Astra Zeneca
7.11.1 Astra Zeneca Company Summary
7.11.2 Astra Zeneca Business Overview
7.11.3 Astra Zeneca Anti-HER2 Therapy Major Product Offerings
7.11.4 Astra Zeneca Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.11.5 Astra Zeneca Key News & Latest Developments
7.12 Daiichi Sankyo
7.12.1 Daiichi Sankyo Company Summary
7.12.2 Daiichi Sankyo Business Overview
7.12.3 Daiichi Sankyo Anti-HER2 Therapy Major Product Offerings
7.12.4 Daiichi Sankyo Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.12.5 Daiichi Sankyo Key News & Latest Developments
7.13 Celltrion
7.13.1 Celltrion Company Summary
7.13.2 Celltrion Business Overview
7.13.3 Celltrion Anti-HER2 Therapy Major Product Offerings
7.13.4 Celltrion Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.13.5 Celltrion Key News & Latest Developments
7.14 Teva
7.14.1 Teva Company Summary
7.14.2 Teva Business Overview
7.14.3 Teva Anti-HER2 Therapy Major Product Offerings
7.14.4 Teva Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.14.5 Teva Key News & Latest Developments
7.15 Biocon
7.15.1 Biocon Company Summary
7.15.2 Biocon Business Overview
7.15.3 Biocon Anti-HER2 Therapy Major Product Offerings
7.15.4 Biocon Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.15.5 Biocon Key News & Latest Developments
7.16 Viatris
7.16.1 Viatris Company Summary
7.16.2 Viatris Business Overview
7.16.3 Viatris Anti-HER2 Therapy Major Product Offerings
7.16.4 Viatris Anti-HER2 Therapy Revenue in Global Market (2018-2023)
7.16.5 Viatris Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-HER2 Therapy Market Opportunities & Trends in Global Market
Table 2. Anti-HER2 Therapy Market Drivers in Global Market
Table 3. Anti-HER2 Therapy Market Restraints in Global Market
Table 4. Key Players of Anti-HER2 Therapy in Global Market
Table 5. Top Anti-HER2 Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-HER2 Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-HER2 Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-HER2 Therapy Product Type
Table 9. List of Global Tier 1 Anti-HER2 Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-HER2 Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-HER2 Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Anti-HER2 Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-HER2 Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Anti-HER2 Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Anti-HER2 Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-HER2 Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Anti-HER2 Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Anti-HER2 Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-HER2 Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-HER2 Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-HER2 Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-HER2 Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-HER2 Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-HER2 Therapy Revenue, (US$, Mn), 2024-2029
Table 30. GlaxoSmithKline Company Summary
Table 31. GlaxoSmithKline Anti-HER2 Therapy Product Offerings
Table 32. GlaxoSmithKline Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Bayer Company Summary
Table 35. Bayer Anti-HER2 Therapy Product Offerings
Table 36. Bayer Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer Key News & Latest Developments
Table 38. Abbott Company Summary
Table 39. Abbott Anti-HER2 Therapy Product Offerings
Table 40. Abbott Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Abbott Key News & Latest Developments
Table 42. AbbVie Company Summary
Table 43. AbbVie Anti-HER2 Therapy Product Offerings
Table 44. AbbVie Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. AbbVie Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Anti-HER2 Therapy Product Offerings
Table 48. Pfizer Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Anti-HER2 Therapy Product Offerings
Table 52. Sanofi Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Anti-HER2 Therapy Product Offerings
Table 56. Merck Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Glenmark Pharmaceuticals Company Summary
Table 59. Glenmark Pharmaceuticals Anti-HER2 Therapy Product Offerings
Table 60. Glenmark Pharmaceuticals Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Glenmark Pharmaceuticals Key News & Latest Developments
Table 62. Roche Company Summary
Table 63. Roche Anti-HER2 Therapy Product Offerings
Table 64. Roche Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Roche Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Anti-HER2 Therapy Product Offerings
Table 68. Novartis Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. Astra Zeneca Company Summary
Table 71. Astra Zeneca Anti-HER2 Therapy Product Offerings
Table 72. Astra Zeneca Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Astra Zeneca Key News & Latest Developments
Table 74. Daiichi Sankyo Company Summary
Table 75. Daiichi Sankyo Anti-HER2 Therapy Product Offerings
Table 76. Daiichi Sankyo Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Daiichi Sankyo Key News & Latest Developments
Table 78. Celltrion Company Summary
Table 79. Celltrion Anti-HER2 Therapy Product Offerings
Table 80. Celltrion Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Celltrion Key News & Latest Developments
Table 82. Teva Company Summary
Table 83. Teva Anti-HER2 Therapy Product Offerings
Table 84. Teva Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Teva Key News & Latest Developments
Table 86. Biocon Company Summary
Table 87. Biocon Anti-HER2 Therapy Product Offerings
Table 88. Biocon Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. Biocon Key News & Latest Developments
Table 90. Viatris Company Summary
Table 91. Viatris Anti-HER2 Therapy Product Offerings
Table 92. Viatris Anti-HER2 Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Viatris Key News & Latest Developments
List of Figures
Figure 1. Anti-HER2 Therapy Segment by Type in 2022
Figure 2. Anti-HER2 Therapy Segment by Application in 2022
Figure 3. Global Anti-HER2 Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-HER2 Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-HER2 Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-HER2 Therapy Revenue in 2022
Figure 8. By Type - Global Anti-HER2 Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Anti-HER2 Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Anti-HER2 Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Anti-HER2 Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Anti-HER2 Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Anti-HER2 Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Anti-HER2 Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Anti-HER2 Therapy Revenue Market Share, 2018-2029
Figure 16. US Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Anti-HER2 Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Anti-HER2 Therapy Revenue Market Share, 2018-2029
Figure 28. China Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Anti-HER2 Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Anti-HER2 Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Anti-HER2 Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. GlaxoSmithKline Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Abbott Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AbbVie Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sanofi Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Glenmark Pharmaceuticals Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Roche Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Novartis Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Astra Zeneca Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Daiichi Sankyo Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Celltrion Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Teva Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Biocon Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Viatris Anti-HER2 Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
